PAVmed (PAVM) Capital Expenditures (QoQ) (2016 - 2025)
PAVmed (PAVM) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | PAVmed | 11.18 Mn | 9.64 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 366.67% |
| Sep 30, 2025 | -62.50% |
| Jun 30, 2025 | 33.33% |
| Mar 31, 2025 | 50.00% |
| Jun 30, 2024 | -92.86% |
| Mar 31, 2024 | -77.05% |
| Dec 31, 2023 | 916.67% |
| Sep 30, 2023 | 20.00% |
| Jun 30, 2023 | -42.31% |
| Mar 31, 2023 | -91.28% |
| Dec 31, 2022 | -5.70% |
| Sep 30, 2022 | -10.23% |
| Jun 30, 2022 | -38.68% |
| Mar 31, 2022 | -55.05% |
| Dec 31, 2021 | 3,548.57% |
| Sep 30, 2021 | -71.07% |
| Jun 30, 2021 | 236.11% |
| Mar 31, 2021 | 350.00% |
| Dec 31, 2020 | 166.67% |
| Sep 30, 2020 | -92.86% |